^
7d
NIRO: Norethindrone Impact on Receptiva Outcomes (clinicaltrials.gov)
P=N/A, N=99, Completed, Inception Fertility Research Institute, LLC | Active, not recruiting --> Completed | N=700 --> 99 | Trial completion date: Jul 2026 --> Dec 2025
Trial completion • Enrollment change • Trial completion date
|
BCL6 (B-cell CLL/lymphoma 6)
|
leuprolide acetate for depot suspension
14d
ADOPT: Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy (clinicaltrials.gov)
P3, N=280, Active, not recruiting, University Medical Center Groningen | Not yet recruiting --> Active, not recruiting
Enrollment closed
|
Eligard (leuprolide acetate)
26d
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments (clinicaltrials.gov)
P=N/A, N=101, Completed, University of Chicago | Trial primary completion date: Dec 2027 --> Apr 2025 | Recruiting --> Completed | Trial completion date: Dec 2027 --> Apr 2025
Trial completion • Trial completion date • Trial primary completion date
28d
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires (clinicaltrials.gov)
P=N/A, N=100, Recruiting, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Trial completion date: May 2026 --> May 2027 | Trial primary completion date: May 2026 --> May 2027
Trial completion date • Trial primary completion date
|
cyclophosphamide
29d
Case Report: Successful natural conception and delivery in a primary cancer survivor involving the reproductive, respiratory, and endocrine systems auth. (PubMed, Front Oncol)
She received six cycles of postoperative leuprorelin therapy...The polyp was resected, and the patient received a 14-day course of anti-infective therapy with metronidazole and levofloxacin, after which she was guided by natural conception...It establishes an MDT management pathway encompassing "determination of oncologic remission status, intervention for reversible fertility-compromising factors, and cross-trimester monitoring." This confirms that natural pregnancy is safe and feasible for patients in cancer remission, with multi-disciplinary collaboration and rigorous monitoring. The absence of postpartum neoplasm recurrence and abnormalities in offspring provides a practical paradigm for fertility management in patients with MPNs.
Journal
|
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 mutation
|
leuprolide acetate for depot suspension
1m
Trial completion
1m
New P3 trial
|
triptorelin • goserelin acetate
1m
Enrollment open
|
Eligard (leuprolide acetate)
1m
Retrospective analysis of growth hormone effects on growth and adenoma volume in children with pituitary microadenoma. (PubMed, Transl Pediatr)
Female and male subgroups differed significantly in PAH and BA-CA improvements (P<0.05). Combined GH and leuprorelin enhances linear growth and delayed bone maturation in children with PM and compromised PAH, without promoting tumor growth or sustained IGF-1 elevation.
Retrospective data • Journal
|
IGF1 (Insulin-like growth factor 1)
|
leuprolide acetate for depot suspension